迪巧品牌怎么样 申请店铺

我要投票 迪巧在钙片行业中的票数:10 更新时间:2024-11-21
迪巧是哪个国家的品牌?「迪巧」是安士制药(中山)有限公司旗下著名品牌。该品牌发源于广东,由创始人徐清波在2003-09-19期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
迪巧怎么样

迪巧是由美国安士制药有限公司按F.LA标准在美国生产的品牌产品。精选全球50多个优质钙源,是经过国际先进工艺提纯的精制碳酸钙,安全性极高。迪巧科学添加了维生素D3,具有安全、足量、好吸收的三大优点。同时,迪巧针对中国不同年龄段人群对钙制剂需求的特点,特别设计了个性配方和口味。有专为0-3岁宝宝设计的迪巧小儿碳酸钙D3颗粒,专为3岁以上儿童设计的迪巧儿童维D钙咀嚼片,专为成人计的迪巧维D钙咀嚼片以及专为更年期女性设计的迪巧秀源女性片。

迪巧是中国优生科学协会唯一推荐钙补充剂,经中国优生科学协会审核论证,连续10年被作为唯一推荐补钙制剂。2010年中国家庭药箱调查显示,迪巧名列中国居民信赖的家庭常备药排名前三。该调查由中国非处方药物协会、中国医药质量管理协会、中国药学会发布。迪巧荣获中国健康年度总评榜“最受欢迎补钙用药”。2010年39健康网开展了健康年度总评榜,由网民自行投票选出最欢迎的药品品牌,迪巧荣获最受欢迎补钙用药之一。迪巧连续3年荣获“健康中国2010中国药品品牌榜”上榜品牌称号。迪巧连续3年荣获“2008-2009年度店员推荐率最高品牌”。2009年10月29日至31日,《中国药店》杂志社举办了第九届中国药店高峰论坛暨"2008-2009年度店员推荐率最高品牌"揭晓会议,来自全国连锁店、及卫生部、国家药监局的百余人到场。迪巧深受药店专业人员信赖,被大会评为“2008-2009年度店员推荐率最高品牌”。这已经是迪巧连续三年荣获此奖项。

安士制药(中山)有限公司位于广东省中山市火炬开发区国家健康基地,是由以美国安士集团有限公司,中山市健康科技产业基地发展有限公司和百洋集团有限公司为主的几家公司共同投资的一家集科研开发、生产和市场建设于一体的新型医药生产企业。

公司首期占地面积二万多平方米,拥有近一万四千平方米的现代化厂房,已建成两个固体制剂车间、冻干粉针车间、软胶囊车间和质检中心。全部生产车间都通过了国家和省食品药品监督管理局认证中心的GMP认证。固体制剂车间于2010年5月通过美国FDA现场验证。

安士以科研开发为先导,研究开发自产产品。同时引进国外先进生产技术及产品信息,已形成的迪巧系列补钙制剂为国内名列前茅的大品种。此外,安士一直致力于处方药出口美国为主攻目标,培育一支适应国际化生产要求的管理团队和员工队伍。

2007年3月,安士生物科技(中山)有限公司成立,专门从事保健品的软胶囊研发和生产,从而满足软胶囊制剂在国内外市场销售快速发展的需要。

安士制药(中山)有限公司的宗旨是进一步提高安士品牌的美誉度和信任度,极大地丰富安士与人类健康息息相关的品牌内涵。公司的目标是建立一个适应新剂型、新品种发展的药品生产基地,努力在制药市场上形成一个重要的、诚信可靠的企业,为人类的健康事业做出贡献。

Diqiao is a brand product manufactured in the United States by axis Pharmaceutical Co., Ltd. according to f.la standard. More than 50 high-quality calcium sources in the world are selected. They are refined calcium carbonate purified by international advanced technology, with high safety. Diqiao added vitamin D3 scientifically, which has three advantages of safety, sufficient quantity and good absorption. At the same time, Diqiao specially designed the individual formula and taste according to the characteristics of different age groups in China. There are Diqiao children's calcium carbonate D3 granules specially designed for 0-3 years old children, Diqiao children's vitamin D calcium chewable tablets specially designed for children over 3 years old, Diqiao vitamin D calcium chewable tablets specially designed for adults and Diqiao Xiuyuan women's tablets specially designed for menopausal women. Diqiao is the only calcium supplement recommended by China eugenics Association. It has been the only calcium supplement recommended by China eugenics Association for 10 consecutive years. According to the 2010 survey of family medicine kits in China, Diqiao ranked in the top three list of household medicines trusted by Chinese residents. The survey was released by China over the counter drug association, China Pharmaceutical Quality Management Association and China Pharmaceutical Association. Diqiao won the "most popular calcium supplement" in China's annual health review. In 2010, 39 health.com launched the annual health evaluation list, and the Internet users voted to select the most popular drug brand. Diqiao won one of the most popular calcium supplements. Diqiao has won the title of "healthy China 2010 Chinese drug brand list" for three consecutive years. Diqiao has been awarded "the highest brand recommended by shop assistants in 2008-2009" for three consecutive years. From October 29 to 31, 2009, China drugstore magazine Co., Ltd. held the 9th China drugstore Summit Forum and the unveiling meeting of "the highest recommended brand of staff in 2008-2009". More than 100 people from the national chain stores, the Ministry of health and the State Food and Drug Administration attended. Diqiao is deeply trusted by drugstore professionals and was rated as the "top brand with the highest recommended rate of salesmen in 2008-2009" by the conference. This is the third consecutive year that Diqiao has won this award. Anshi Pharmaceutical (Zhongshan) Co., Ltd. is located in the national health base of Torch Development Zone, Zhongshan City, Guangdong Province. It is a new pharmaceutical production enterprise, which is jointly invested by several companies mainly including Anshi Group Co., Ltd., Zhongshan Health Science and Technology Industrial Base Development Co., Ltd. and Baiyang Group Co., Ltd. The first phase of the company covers an area of more than 20000 square meters, with a modern plant of nearly 14000 square meters. Two solid preparation workshops, freeze-dried powder injection workshops, soft capsule workshops and quality inspection centers have been built. All production workshops have passed the GMP certification of national and provincial food and Drug Administration certification center. The solid preparation workshop passed the FDA field verification in May 2010. With scientific research and development as the guide, axis researches and develops its own products. At the same time, the introduction of foreign advanced production technology and product information, has formed Diqiao series of calcium supplements for the domestic top big varieties. In addition, axis has been committed to the export of prescription drugs to the United States as the main goal, and cultivate a management team and staff team to meet the requirements of international production. In March 2007, axis Biotechnology (Zhongshan) Co., Ltd. was established, specializing in the research, development and production of soft capsules for health products, so as to meet the needs of rapid development of soft capsule sales in domestic and foreign markets. The aim of axis Pharmaceutical (Zhongshan) Co., Ltd. is to further improve the reputation and trust of axis brand and greatly enrich the brand connotation of axis closely related to human health. The company's goal is to establish a pharmaceutical production base to adapt to the development of new dosage forms and new varieties, strive to form an important, honest and reliable enterprise in the pharmaceutical market, and make contributions to human health.

本文链接: https://brand.waitui.com/7cdc17c05.html 联系电话:076023898866

千城特选小程序码

7×24h 快讯

国资委:目前最紧迫的是要向前瞻性战略性新兴产业集中

36氪获悉,据国务院国资委官网,11月19日至20日,国务院国资委党委举办理论学习中心组集体学习会暨厅局级干部研修班。大家一致认为,要完善国有经济布局优化和结构调整机制,推动中央企业加快构建现代化产业体系。要谋划好国资央企“十五五”规划,把行业研究透、家底理清楚,科学严谨、能够落地。要更加有效推进国有资本“三个集中”,目前最紧迫的是要向前瞻性战略性新兴产业集中,在维护国家国防安全、粮食安全、能源安全等方面发挥战略安全兜底作用,深入推进战略性、专业化重组。

33分钟前

人民银行科技司:正在加紧出台金融业数据跨境流动合规指南

在11月21日2024年世界互联网大会乌镇峰会“数据治理论坛”上,中国人民银行科技司司长李伟介绍,年初,在国家网信部门统筹指导下,人民银行会同其他金融管理部门开展研究,编制了《促进和规范金融业数据跨境流动合规指南》。目前,《指南》正在加紧出台中。《指南》明确,不含金融重要数据或个人信息的数据,在履行法律规定等一般性合规义务,以及满足国家网信部门、金融管理部门有关规定的前提下,可以自由跨境流动,自主向境外提供。(中证报)

33分钟前

搜狗输入法打造全新AI搜索体验,输入即搜索

36氪获悉,11月21日,腾讯搜狗输入法进行全新升级,在腾讯混元大模型技术的支持下,推出和升级AI搜索、AI快查等重要功能,实现“输入即搜索”,在学习、办公、社交等场景中,做到边聊边搜、边写边搜,智能化提供参考信息。更重要的是,用户将可免费使用全部AI服务。

33分钟前

阿里巴巴整合国内和海外电商,成立电商事业群,由蒋凡担任CEO

36氪独家获悉,11月21日,阿里巴巴集团CEO吴泳铭发布内部邮件,宣布整合国内和海外电商,成立电商事业群,由蒋凡担任CEO,向吴泳铭汇报。据了解,新的电商事业群将全面整合淘宝天猫集团、国际数字商业集团以及1688、闲鱼等电商业务,形成覆盖国内外全产业链的业务集群。信中表示,“通过整合集团内的所有电商资源,激发多年沉淀的能力,服务好国内和全球消费者,同时帮助更多中小企业同步拓展国内及海外市场。”

34分钟前

快手-W获南向资金净买入7亿港元

南向资金今日净买入46.66亿元。港股通(沪)方面,快手-W、阿里巴巴-W分别获净买入7.0亿港元、1.4亿港元;小米集团-W净卖出额居首,金额为2.04亿港元;港股通(深)方面,阿里巴巴-W、小米集团-W分别获净买入2.83亿港元、1.84亿港元;融创中国净卖出额居首,金额为0.77亿港元。(第一财经)

34分钟前

本页详细列出关于龙牡的品牌信息,含品牌所属公司介绍,龙牡所处行业的品牌地位及优势。
咨询